Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.

Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.
Condition:   Unresectable Stage III NSCLC
Intervention:   Device: Multiparametric Mobile Technology
Sponsor:   AstraZeneca
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 9, 2020 / by / in
Comments